National Resource Center for Chinese Materia Medica, Academy of Chinese Medical Sciences, Beijing 100700, China.
BMC Genomics. 2014 Jan 28;15:73. doi: 10.1186/1471-2164-15-73.
Plant natural products have been co-opted for millennia by humans for various uses such as flavor, fragrances, and medicines. These compounds often are only produced in relatively low amounts and are difficult to chemically synthesize, limiting access. While elucidation of the underlying biosynthetic processes might help alleviate these issues (e.g., via metabolic engineering), investigation of this is hindered by the low levels of relevant gene expression and expansion of the corresponding enzymatic gene families. However, the often-inducible nature of such metabolic processes enables selection of those genes whose expression pattern indicates a role in production of the targeted natural product.
Here, we combine metabolomics and transcriptomics to investigate the inducible biosynthesis of the bioactive diterpenoid tanshinones from the Chinese medicinal herb, Salvia miltiorrhiza (Danshen). Untargeted metabolomics investigation of elicited hairy root cultures indicated that tanshinone production was a dominant component of the metabolic response, increasing at later time points. A transcriptomic approach was applied to not only define a comprehensive transcriptome (comprised of 20,972 non-redundant genes), but also its response to induction, revealing 6,358 genes that exhibited differential expression, with significant enrichment for up-regulation of genes involved in stress, stimulus and immune response processes. Consistent with our metabolomics analysis, there appears to be a slower but more sustained increased in transcript levels of known genes from diterpenoid and, more specifically, tanshinone biosynthesis. Among the co-regulated genes were 70 transcription factors and 8 cytochromes P450, providing targets for future investigation.
Our results indicate a biphasic response of Danshen terpenoid metabolism to elicitation, with early induction of sesqui- and tri- terpenoid biosynthesis, followed by later and more sustained production of the diterpenoid tanshinones. Our data provides a firm foundation for further elucidation of tanshinone and other inducible natural product metabolism in Danshen.
人类几千年来一直将植物天然产物用于各种用途,如调味、香料和药物。这些化合物通常只产生相对较低的量,并且难以化学合成,限制了它们的获取。虽然阐明潜在的生物合成过程可能有助于缓解这些问题(例如,通过代谢工程),但对这方面的研究受到相关基因表达水平低和相应酶基因家族扩展的阻碍。然而,这些代谢过程通常具有诱导性,这使得选择那些表达模式表明其在目标天然产物生产中起作用的基因成为可能。
在这里,我们结合代谢组学和转录组学研究了来自中国药用植物丹参(Salvia miltiorrhiza)的生物活性二萜丹参酮的诱导生物合成。对诱导发根培养物的非靶向代谢组学研究表明,丹参酮的生产是代谢反应的主要组成部分,在后期时间点增加。转录组学方法不仅用于定义一个全面的转录组(由 20972 个非冗余基因组成),还用于定义其对诱导的反应,揭示了 6358 个表现出差异表达的基因,其中涉及应激、刺激和免疫反应过程的基因显著上调。与我们的代谢组学分析一致,在已知的二萜,更具体地说是丹参酮生物合成基因的转录水平上似乎有一个较慢但更持续的增加。在共调控基因中包括 70 个转录因子和 8 个细胞色素 P450,为未来的研究提供了目标。
我们的结果表明,丹参萜类代谢对诱导的反应呈双相性,早期诱导倍半萜和三萜生物合成,随后是二萜丹参酮的后期和更持续的产生。我们的数据为进一步阐明丹参中丹参酮和其他诱导天然产物代谢提供了坚实的基础。